This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

23 Jun 2021

LSNE Receives Approval from AEMPS to Manufacture Biotechnology-based Therapeutic Products

LSNE Contract Manufacturing Clinical and Commercial GMP Manufacturing Facility - León, Spain

LSNE expands capabilities for aseptic fill finish of high-value biologics in Europe. This important approval builds upon LSNE’s well-established capabilities in providing aseptic fill finish of biologic products for clients at its US facilities.  These products include monoclonal antibodies, fusion proteins, replacement enzymes, plasmids, capsids, and oligonucleotides.

LSNE Contract Manufacturing, a leading contract development and manufacturing organization, is pleased to announce that the Spanish Agency of Medicines and Medical Devices (AEMPS) has approved the manufacturing of clinical stage biotechnology based therapeutic products at its aseptic fill finish facility in León, Spain.

Mentioned Companies
LSNE Contract Manufacturing
View company profile